Interestingly, in addition to mutations in MYCN, we also noticed recurrent (although not frequent) mutations in three other genes in the MYC/MTOR regulatory network, i.e., MTOR, DYRK3, and AMBRA1 (Figure 4), which have not been reported as mutated in BCC. Here, MYCN is linked to skin basal cell carcinoma.